Corteva (NYSE:CTVA – Get Free Report) will likely be issuing its Q4 2025 results after the market closes on Tuesday, February 3rd. Analysts expect the company to announce earnings of $0.22 per share and revenue of $4.2281 billion for the quarter. Interested persons are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Wednesday, February 4, 2026 at 9:00 AM ET.
Corteva (NYSE:CTVA – Get Free Report) last released its earnings results on Tuesday, November 4th. The company reported ($0.23) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.49) by $0.26. Corteva had a net margin of 9.19% and a return on equity of 9.37%. The firm had revenue of $2.62 billion during the quarter, compared to the consensus estimate of $2.47 billion. During the same period in the prior year, the firm earned ($0.49) EPS. The company’s revenue was up 6.5% compared to the same quarter last year. On average, analysts expect Corteva to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Corteva Trading Up 1.3%
Shares of CTVA stock opened at $72.60 on Tuesday. The company has a quick ratio of 1.07, a current ratio of 1.58 and a debt-to-equity ratio of 0.07. The firm has a market cap of $49.06 billion, a P/E ratio of 31.03, a PEG ratio of 1.82 and a beta of 0.74. The company has a 50 day moving average of $67.43 and a 200-day moving average of $68.33. Corteva has a 12-month low of $53.40 and a 12-month high of $77.41.
Corteva Announces Dividend
Analysts Set New Price Targets
CTVA has been the topic of a number of recent research reports. Jefferies Financial Group dropped their price target on Corteva from $92.00 to $85.00 in a research report on Thursday, October 2nd. Argus raised shares of Corteva to a “strong-buy” rating in a report on Friday, January 16th. The Goldman Sachs Group lifted their target price on shares of Corteva from $77.00 to $78.00 and gave the stock a “buy” rating in a research note on Tuesday, December 16th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Corteva from $90.00 to $85.00 and set a “buy” rating on the stock in a research report on Thursday, November 6th. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $76.00 price objective on shares of Corteva in a report on Friday, November 7th. Two analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $79.47.
Check Out Our Latest Stock Report on Corteva
Institutional Trading of Corteva
A number of large investors have recently modified their holdings of the business. Kelleher Financial Advisors grew its position in Corteva by 3.8% in the third quarter. Kelleher Financial Advisors now owns 4,594 shares of the company’s stock worth $311,000 after acquiring an additional 170 shares in the last quarter. Binnacle Investments Inc boosted its holdings in shares of Corteva by 54.7% in the 2nd quarter. Binnacle Investments Inc now owns 512 shares of the company’s stock worth $38,000 after purchasing an additional 181 shares in the last quarter. Cresset Asset Management LLC boosted its holdings in shares of Corteva by 2.6% in the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after purchasing an additional 181 shares in the last quarter. Sunbelt Securities Inc. increased its position in shares of Corteva by 52.8% during the 3rd quarter. Sunbelt Securities Inc. now owns 923 shares of the company’s stock valued at $62,000 after purchasing an additional 319 shares during the last quarter. Finally, JPL Wealth Management LLC purchased a new position in shares of Corteva during the 3rd quarter valued at about $25,000. Institutional investors own 81.54% of the company’s stock.
Corteva Company Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Further Reading
- Five stocks we like better than Corteva
- How a Family Trust May Be Able To Help Preserve Your Wealth
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The $100 Trillion AI Story No One Is Telling You
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
